ESC 365
ESC 365
Sign in

    Back

    SGLT2 inhibitors across the spectrum of heart failure - discussion.

    21 May 2022 (14:33 - 14:45)
    Organised by:
    Congress Presentation Part of: SGLT2 inhibitors across the spectrum of heart failure Chronic Heart Failure HFA Premium Access Heart Failure 2022

    Video

    Sign in for access options

    4 More presentations in this session

    Presentation thumbnail
    Decoding cardio-protection with SGLT2 inhibitors: new insights into cardio-renal mechanisms.
    Professor P. Seferovic (Belgrade, RS)
    Slides Video
    Presentation thumbnail
    SGLT2 inhibitors: major cardiovascular outcomes in ambulatory patients with HFrEF.
    Professor G. Rosano (London, GB)
    Slides Video
    Presentation thumbnail
    SGLT2 inhibitors in worsening and decompensated heart failure: a promising perspective.
    Professor P. Ponikowski (Wroclaw, PL)
    Slides Video
    Presentation thumbnail
    SGLT2 inhibitors in HFmrEF and HFpEF: fulfilling an unmet need?
    Professor M. Petrie (Glasgow, GB)
    Slides Video

    Access the full session

    Session thumbnail
    SGLT2 inhibitors across the spectrum of heart failure
    Video

    The Event

    Event poster

    Heart Failure 2022

    21 May 2022 14:33 CET
    You may be interested in
    thumbnail
    Congress Session
    Bridging gaps in heart failure care: primary care trends, exercise, kidney function, and global health perspectives
    Logo
    thumbnail
    Congress Session
    Nursing and Allied Professions Investigator Award
    Logo
    thumbnail
    Congress Session
    Which device might help your HFpEF patient?
    Logo